Innovations developed at least in part by faculty at UB’s School of Medicine and Biomedical Sciences accounted for nearly 40 percent of the provisional patent applications filed by the university in 2012.
UB researchers have identified specific roles for two innate immune pathways that drive acute lung injury—findings that may lead to the first treatment or preventive strategy for the condition.
UB researchers will use a $1.6 million grant from the National Institutes of Health to develop the first vaccine against an understudied bacterium that causes at least 10 percent of middle ear infections in children.
Kate Rittenhouse-Olson, PhD, professor of biotechnical and clinical laboratory sciences, and Ernesto De Nardin, PhD, adjunct professor of microbiology and immunology, have co-authored a clinical immunology textbook.
UB microbiologists studying bacterial colonization in mice have discovered how the bacteria associated with pneumonia, middle ear infections and other illnesses acquire and spread resistance.
Patient Voices Network, a partnership between the Department of Family Medicine’s Primary Care Research Institute and Jericho Road Ministries, recently held a free breast cancer awareness event on Buffalo’s East Side.
Laurie K. Read, PhD, has won a four-year, $1.6 million NIH grant to study the mechanisms and regulation of RNA editing in the parasite responsible for African sleeping sickness.
Biomedical researchers have discovered a novel, previously unrecognized set of genes essential for the growth of potentially lethal drug-resistant bacteria.
Biochemistry professor Mark R. O’Brian, PhD, has won a $1.1 million grant from the National Institutes of Health to study regulation of bacterial manganese metabolism.
Leonard H. Epstein, PhD, has been honored with the 2012 Stockton Kimball Award for outstanding scientific accomplishment as well as significant service to the university.
Margarita L. Dubocovich, PhD, chair of the Department of Pharmacology and Toxicology, has been named the inaugural senior associate dean for inclusion and cultural enhancement.
A T35 training grant from the NIH is providing stipends for UB medical students to participate in mentored research projects this summer at UB and Roswell Park Comprehensive Cancer Center.
Kunle Odunsi, director of RPCI’s Center for Immunotherapy and UB professor of gynecology and obstetrics, is leading a phase 1 clinical trial of the dendritic cell vaccine.
Paresh Dandona and colleagues have received a grant to further a study that found that a drug used to treat Type 2 diabetes could also help Type 1 diabetics.
Gil I. Wolfe, MD, was installed as the The Irvin and Rosemary Smith Professor and Chair in Neurology Feb. 17 in a ceremony presided over by Satish K. Tripathi and Michael E. Cain, MD.
